10x Genomics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC TXG

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

169,589

Value ($000)

2,766

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,766	0.0%	169,589	12/31/2025
2025 Q3	11/14/2025	1,735	0.0%	148,387	9/30/2025
2025 Q2	8/14/2025	3,041	0.0%	262,648	6/30/2025
2025 Q1	5/19/2025	62,016	0.0%	7,103,768	3/31/2025
2024 Q4	2/14/2025	30,394	0.0%	2,116,573	12/31/2024
2024 Q3	11/14/2024	43,421	0.0%	1,922,985	9/30/2024
2024 Q2	8/14/2024	37,470	0.0%	1,926,483	6/30/2024
2024 Q1	5/15/2024	5,055	0.0%	134,681	3/31/2024
2023 Q4	2/14/2024	7,441	0.0%	132,964	12/31/2023
2023 Q3	11/13/2023	5,517	0.0%	133,741	9/30/2023
2023 Q2	8/11/2023	7,478	0.0%	134,041	6/30/2023
2023 Q1	5/15/2023	7,478	0.0%	134,041	3/31/2023
2022 Q4	2/14/2023	4,682	0.0%	128,495	12/31/2022
2022 Q3	11/14/2022	3,689	0.0%	129,513	9/30/2022
2022 Q2	8/12/2022	20,785	0.0%	459,342	6/30/2022
2022 Q1	5/16/2022	42,200	0.0%	554,753	3/31/2022
2021 Q4	2/14/2022	74,052	0.0%	497,129	12/31/2021
2021 Q3	11/15/2021	76,907	0.0%	528,280	9/30/2021
2021 Q2	8/16/2021	101,426	0.0%	517,953	6/30/2021
2021 Q1	5/14/2021	90,086	0.0%	497,714	3/31/2021
2020 Q4	3/1/2021	87,949	0.0%	621,108	12/31/2020
2020 Q3	11/13/2020	54,925	0.0%	440,531	9/30/2020
2020 Q2	8/14/2020	35,311	0.0%	395,381	6/30/2020
2020 Q1	5/15/2020	22,622	0.0%	362,992	3/31/2020
2019 Q4	2/14/2020	27,640	0.0%	362,487	12/31/2019